Paul Hastings

President, Chief Executive Officer & Director at Nkarta, Inc.

Paul Hastings

Paul Hastings

President, Chief Executive Officer & Director at Nkarta, Inc.

Overview
Career Highlights

CHIRON Biopharmaceuticals
Genzyme Europe BV
Worldwide Therapeutics.

RelSci Relationships

939

Number of Boards

18

Birthday

1960

Age

61

Relationships
RelSci Relationships are individuals Paul Hastings likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, Chief Executive & Operating Officer at Pacira Biosciences, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Co-Founder at Mereo BioPharma Group Plc

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Sutro Biopharma, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Codexis, Inc.

Relationship likelihood: Strong

General Counsel & Secretary at Optivia Biotechnology, Inc.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Amyris, Inc.

Relationship likelihood: Strong

Scientific Founder at Nkarta, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Chairman at CytomX Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Paul Hastings
Potential Connections via
Relationship Science
You
Paul Hastings
President, Chief Executive Officer & Director at Nkarta, Inc.
Education
Bachelor of Science in Pharmacy

The University of Rhode Island (commonly referred to as URI) is the principal public research as well as the land grant and sea grant university for the state of Rhode Island. Its main campus is located in the village of Kingston in southern Rhode Island. Additionally, smaller campuses include the Feinstein Campus in Providence, the Narragansett Bay Campus in Narragansett, and the W. Alton Jones Campus in West Greenwich.

Career History
President, Chief Executive Officer & Director
2018 - Current

Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.

Vice President, Sales & Marketing
Tenure Unconfirmed

Amgen Boulder, Inc., part of Amgen, Inc., is an American company located in Longmont, CO. The firm discovers, develops, and produces protein-based human pharmaceuticals.

Chairman, President & Chief Executive Officer
2006 - 2018

OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Boards & Committees
Director
Prior - 2011

Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications.Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California.

Director
2002 - Prior

QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT).

Chairman, Board of Directors
Prior

BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.

Transactions
Details Hidden

Nkarta, Inc. issued USD Common Stock

Details Hidden

Nkarta, Inc. raised money in a private placement transaction

Details Hidden

OncoMed Pharmaceuticals, Inc. raised money in a private placement transaction

Investments
Details Hidden

OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paul Hastings. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paul Hastings's profile does not indicate a business or promotional relationship of any kind between RelSci and Paul Hastings.